Your browser doesn't support javascript.
loading
Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets.
Mata, Elena; Díaz-López, Antonio; Martín-Moreno, Ana M; Sánchez-Beato, Margarita; Varela, Ignacio; Mestre, María J; Santonja, Carlos; Burgos, Fernando; Menárguez, Javier; Estévez, Mónica; Provencio, Mariano; Sánchez-Espiridión, Beatriz; Díaz, Eva; Montalbán, Carlos; Piris, Miguel A; García, Juan F.
Afiliação
  • Mata E; Department of Pathology and Translational Research, MD Anderson Cancer Center Madrid, Madrid, Spain.
  • Díaz-López A; Department of Pathology and Translational Research, MD Anderson Cancer Center Madrid, Madrid, Spain.
  • Martín-Moreno AM; Department of Pathology and Translational Research, MD Anderson Cancer Center Madrid, Madrid, Spain.
  • Sánchez-Beato M; Lymphoma Research Group, Medical Oncology Department, Instituto Investigación Sanitaria Puerta de Hierro (IDIPHIM), Madrid, Spain.
  • Varela I; Instituto de Biomedicina y Biotecnología de Cantabria, IBBTEC (CSIC, Universidad de Cantabria), Santander, Spain.
  • Mestre MJ; Department of Pathology, Hospital Universitario de Móstoles, Madrid, Spain.
  • Santonja C; Department of Pathology, Fundación Jiménez Díaz, Madrid, Spain.
  • Burgos F; Department of Pathology, Hospital Severo Ochoa, Madrid, Spain.
  • Menárguez J; Department of Pathology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Estévez M; Department of Hematology, MD Anderson Cancer Center Madrid, Madrid, Spain.
  • Provencio M; Lymphoma Research Group, Medical Oncology Department, Instituto Investigación Sanitaria Puerta de Hierro (IDIPHIM), Madrid, Spain.
  • Sánchez-Espiridión B; Department of Molecular Translational Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Díaz E; Department of Pathology and Translational Research, MD Anderson Cancer Center Madrid, Madrid, Spain.
  • Montalbán C; Department of Hematology, MD Anderson Cancer Center Madrid, Madrid, Spain.
  • Piris MA; Department of Pathology, Fundación Jiménez Díaz, Madrid, Spain.
  • García JF; Department of Pathology and Translational Research, MD Anderson Cancer Center Madrid, Madrid, Spain.
Oncotarget ; 8(67): 111386-111395, 2017 Dec 19.
Article em En | MEDLINE | ID: mdl-29340061
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha